A6) Travel programs, while that seems simple, go a long way towards evolving as an industry. There are a lot of great programs out there to help with that. Programs built by our industry for our industry and understand the nuances of clinical trials @BBKWorldwide #trialchat
A5 Participation is challenging so that's why historically it has been and will continue to be. We require a lot from patients sites and caregivers and for good reason. Evaluate the study challenges and enhance the experience based on the challenges #trialchat
Q4 Don't forget about the site involvement. We continue to come up with the "new" and the "cool" but it's the sites involvement in the one-to one connection that allows for the new and cool to be used. #trialchat @BBKWorldwide
Q2 a shift to multi platform engagement. Patients and caregivers being able to choose how they want to participate and interact with the study. Travel, reimbursement and digital tools have helped patients and caregivers stay connected to the study. #trialchat @BBKWorldwide
A1 It's all about the patient experience. What are the details of the protocol, what are the burdensome pieces of study participation that exist and how can we as an industry address those burdens to facilitate a positive experience #trialchat